Tea tree oil vagitories

ApprovedSmall molecule

Tea tree oil vagitories is one of 3 small molecule programs targeting Vaginal Inflammation. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Vaginal InflammationActive, not recruiting

Vaginal InflammationApproved

Active, not recruiting

Competition

Competitive Landscape

4 competitors in Vaginal Inflammation

#DrugCompanyPhaseTrials

Aleve

Alnylam Pharmaceuticals

Advil

Tea tree oil vagitories

UUniversity of Sarajevo

Approved

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Vaginal Inflammation1 trial

Use of Vagitories Based on St. John's Wort, Tea Tree Oil and Shepherd's Purse in the Treatment of Vaginal Inflammation

Completed·UUniversity of Sarajevo·Phase 4·NCT04558697·210 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Tea tree oil vagitories. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tea tree oil vagitories compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tea tree oil vagitories. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Sarajevo company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: UUniversity of Sarajevo

Tea tree oil vagitories

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Vaginal Inflammation1 trial

References

Drug Info

Quick Facts

Related News